Carregant...
Overexpression of MCM10 promotes cell proliferation and predicts poor prognosis in prostate cancer
BACKGROUND: Prostate cancer (PCa) is one of the most malignant tumors of the male urogenital system. There is an urgent need to identify novel biomarkers for PCa. METHODS: In this study, we evaluated the expression levels of MCM10 in prostate cancer by analyzing public datasets (including The Cancer...
Guardat en:
| Publicat a: | Prostate |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2018
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6282949/ https://ncbi.nlm.nih.gov/pubmed/30095171 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.23703 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|